DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Konishi, Kazuo ^a,b   Watanabe, Yoshiyuki ^a,c   Shen, Lanlan ^a   Guo, Yi ^a   Castoro, Ryan J ^a   Kondo, Kimie ^a   Chung, Woonbok ^a   Ahmed, Saira ^a   Jelinek, Jaroslav ^a   Boumber, Yanis A ^a   Estecio, Marcos R ^a   Maegawa, Shinji ^a   Kondo, Yutaka ^d   Itoh, Fumio ^c   Imawari, Michio ^b   Hamilton, Stanley R ^a   Issa, Jean Pierre J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CDH1 GENE; CDH13 GENE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; ER ALPHA GENE; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; HPP1 GENE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; METHYLATED CPG ISLAND AMPLIFICATION MICROARRAY; MGMT GENE; MINT1 GENE; MINT2 GENE; MINT31 GENE; MLH1 GENE; P14 GENE; PYROSEQUENCING; THBS1 GENE; TIMP3 GENE; TUMOR GENE; TUMOR SUPPRESSOR GENE; COLORECTAL TUMOR; CPG ISLAND; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; LIVER TUMOR; METASTASIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 81455125557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027889     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130.
2. Potter JD, Slattery ML, Bostick RM, Gapstur SM, (1993) Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545.
3. Kinzler KW, Vogelstein B, (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170.
4. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104: 18654-18659.
5. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, et al. (2008) Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res 14: 2560-2569.
6. Radinsky R, Fidler IJ, (1992) Regulation of tumor cell growth at organ-specific metastases. In Vivo 6: 325-331.
7. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z, (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38: 1043-1048.
8. Esteller M, Gonzalez S, Risques RA, Marcuello E, Mangues R, et al. (2001) K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J Clin Oncol 19: 299-304.
9. Kohonen-Corish MR, Daniel JJ, Chan C, Lin BP, Kwun SY, et al. (2005) Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol 23: 2318-2324.
10. Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, et al. (2007) CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 450: 529-537.
11. Shen L, Catalano PJ, Benson AB 3rd, O'Dwyer P, Hamilton SR, et al. (2007) Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13: 6093-6098.
12. Van Rijnsoever M, Elsaleh H, Joseph D, McCaul K, Iacopetta B, (2003) CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res 9: 2898-2903.
13. Ward RL, Cheong K, Ku SL, Meagher A, O'Connor T, et al. (2003) Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 21: 3729-3736.
14. Konishi K, Kaneko K, Kurahashi T, Yamamoto T, Kushima M, et al. (2003) A comparison of magnifying and nonmagnifying colonoscopy for diagnosis of colorectal polyps: A prospective study. Gastrointest Endosc 57: 48-53.
15. Clark SJ, Harrison J, Paul CL, Frommer M, (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997.
16. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R, (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150.
17. Konishi K, Shen L, Wang S, Meltzer SJ, Harpaz N, et al. (2007) Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology 132: 1254-1260.
18. Shen L, Kondo Y, Hamilton SR, Rashid A, Issa JP, (2003) P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124: 626-633.
19. Powe DG, Brough JL, Carter GI, Bailey EM, Stetler-Stevenson WG, et al. (1997) TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Br J Cancer 75: 1678-1683.
20. Takeichi M, (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811.
21. Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, et al. (2002) Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62: 3382-3386.
22. Li Q, Ahuja N, Burger PC, Issa JP, (1999) Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene 18: 3284-3289.
23. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, et al. (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97: 1330-1338.
24. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, et al. (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540.
25. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96: 8681-8686.
26. Rhei E, Bogomolniy F, Federici MG, Maresco DL, Offit K, et al. (1998) Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer Res 58: 3193-3196.
27. Toyota M, Ohe-Toyota M, Ahuja N, Issa JP, (2000) Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 97: 710-715.
28. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312.
29. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, et al. (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3: 2023-2036.
30. Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
31. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP, (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196.
32. Issa JP, (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
33. Jones PA, Laird PW, (1999) Cancer epigenetics comes of age. Nat Genet 21: 163-167.
34. Chambers AF, Matrisian LM, (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270.
35. Pulukuri SM, Patibandla S, Patel J, Estes N, Rao JS, (2007) Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors. Oncogene 26: 5229-5237.
36. Lindahl T, Demple B, Robins P, (1982) Suicide inactivation of the E. coli O6-methylguanine-DNA methyltransferase. Embo J 1: 1359-1363.
37. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, et al. (2000) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60: 2368-2371.
38. Park TJ, Han SU, Cho YK, Paik WK, Kim YB, et al. (2001) Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92: 2760-2768.
39. Hiraga J, Kinoshita T, Ohno T, Mori N, Ohashi H, et al. (2006) Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma. Int J Hematol 84: 248-255.
40. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP, (1998) Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58: 5489-5494.